Home » Topics » BioWorld Science

BioWorld Science
RSS

GNT Biotech & Medicals presents new HDAC inhibitors

Nov. 18, 2021

Innate checkpoint inhibitor ASD-141 inhibits tumor growth in colon cancer models

Nov. 18, 2021

Gasherbrum Bio patents GLP-1 receptor agonists

Nov. 18, 2021

p53-PHLDA3-Akt signaling as novel therapeutic target in heart failure

Nov. 18, 2021

Medshine Discovery discloses new MAPK inhibitors

Nov. 18, 2021

Novel STING agonist RVU-27065 shows potency in EMT6 breast cancer model

Nov. 18, 2021

PCC-1, an orally active HPK1 inhibitor with strong antitumor activity

Nov. 18, 2021

Stanford researchers identify means of targeting RBM20 for ameliorating diseased cardiomyocytes

Nov. 18, 2021

Preclinical results presented on a novel conditionally activated IFN-alpha INDUKINE molecule

Nov. 18, 2021

Novel protein ACE2 1-618-DDC-ABD protects against lethal SARS-CoV-2 infection

Nov. 18, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...